Search Results 341-350 of 22989 for Phase

  1. A Phase 1b/2 Study of Onvansertib (PCM-075) in Combination with FOLFIRI and Bevacizumab for Second-Line Treatment of Metastatic Colorectal Cancer in Patients with a KRAS Mutation - Mayo Clinic

    A Phase 1b/2 Study of Onvansertib (PCM-075) in Combination with FOLFIRI and Bevacizumab for Second-Line Treatment of Metastatic Colorectal Cancer in Patients ...

  2. A Global, Randomized, Placebo-controlled Phase 3 Study of Fruquintinib in Patients with Refractory Metastatic Colorectal Cancer - Mayo Clinic

    A Global, Randomized, Placebo-controlled Phase 3 Study of Fruquintinib in Patients with Refractory Metastatic Colorectal Cancer · Share · Facebook · Twitter.

  3. A Phase 2, Multi-center, Open-label Study to Evaluate the Efficacy and Safety of Luspatercept (ACE-536) in Subjects with Myeloproliferative Neoplasm-Associated Myelofibrosis and Anemia with and without Red Blood Cell-Transfusion Dependence - Mayo Clinic

    This is a Phase 2, multicenter, open-label study to evaluate the efficacy and safety of luspatercept in subjects with MPN-associated myelofibrosis and anemia ...

  4. Pre-Clerkship - Curriculum - M.D. Program - Mayo Clinic Alix School of Medicine

    Learn more about the Pre-Clerkship phase of the curriculum for students at Mayo Clinic Alix School of Medicine in Arizona, Florida, and Minnesota.

  5. A Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) as Monotherapy or in Combination With Avastin (Bevacizumab) Compared to Sunitinib in Patients With Untreated Advanced Renal Cell Carcinoma [IMmotion150] - Mayo Clinic

    A Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) as Monotherapy or in Combination With Avastin (Bevacizumab) Compared to Sunitinib in Patients ...

  6. A Phase 2 Study to Assess the Safety and Efficacy of Intravitreal ONL1204 Ophthalmic Solution in Subjects With Mac-off Retinal Detachment - Mayo Clinic

    A Phase 2 Study to Assess the Safety and Efficacy of Intravitreal ONL1204 Ophthalmic Solution in Subjects With Mac-off Retinal Detachment · More about research ...

  7. A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH - Mayo Clinic

    The purpose of this study is evaluation of efruxifermin (EFX) in subjects with compensated cirrhosis due to NASH/MASH. This is a Phase 3, randomized, double- ...

  8. Visionary Study: Phase 3 Trial of Sibeprenlimab in Immunoglobulin A Nephropathy (IgAN) - Mayo Clinic

    The purpose of this study is to evaluate effects on proteinuria and glomerular filtration rate of sibeprenlimab 400 mg subcutaneously (s.c.) Q 4 weeks in adults ...

  9. A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke (REvive) - Mayo Clinic

    A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke (REvive) · Overview · Participation ...

  10. Safusidenib Phase 2 Study In IDH1 Mutant Glioma - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness, safety, and PK of safusidenib erbumine in patients with isocitrate dehydrogenase 1 (IDH1) mutant ...